{"id":"https://openalex.org/W2374587160","doi":null,"title":"The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.","display_name":"The effect of calmodulin antagonist berbaminederivative-EBB on hepatoma in vitro and in vivo.","publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W2374587160","mag":"2374587160","pmid":"https://pubmed.ncbi.nlm.nih.gov/12133551"},"language":"en","primary_location":{"id":"pmid:12133551","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12133551","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chinese medical journal","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002256983","display_name":"Jiewen Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200296433","display_name":"Chinese Academy of Medical Sciences & Peking Union Medical College","ror":"https://ror.org/02drdmm93","country_code":"CN","type":"education","lineage":["https://openalex.org/I200296433"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiewen Liu","raw_affiliation_strings":["Department of Pathology, Institute of Hematology, CAMS & PUMC, Tianjin 300020, China. LiuJW@Publictpt.tj.c","Department of Pathology, Institute of Hematology, CAMS & PUMC, Tianjin 300020, China.c"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Institute of Hematology, CAMS & PUMC, Tianjin 300020, China. LiuJW@Publictpt.tj.c","institution_ids":["https://openalex.org/I200296433"]},{"raw_affiliation_string":"Department of Pathology, Institute of Hematology, CAMS & PUMC, Tianjin 300020, China.c","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041745561","display_name":"Shuling Qi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuling Qi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100303589","display_name":"Hui\u2010Fang Zhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huifang Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024608493","display_name":"Jinhong Zhang","orcid":"https://orcid.org/0000-0003-4741-3040","observed_orcids":["https://orcid.org/0000-0003-4741-3040"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jinhong Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100448016","display_name":"Zhuo Li","orcid":"https://orcid.org/0000-0001-6441-2117","observed_orcids":["https://orcid.org/0000-0001-6441-2117"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhuo Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100451008","display_name":"Tong Wang","orcid":"https://orcid.org/0000-0002-6667-6498","observed_orcids":["https://orcid.org/0000-0002-6667-6498"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tong Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4082,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.66684222,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"115","issue":"5","first_page":"759","last_page":"62"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.5932999849319458,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.5932999849319458,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.3091000020503998,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.021900000050663948,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/calmodulin-antagonists","display_name":"calmodulin antagonists","score":0.8730000257492065},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9150000214576721},{"id":"https://openalex.org/keywords/5-fluorouracil-combination-therapy","display_name":"5-fluorouracil combination therapy","score":0.8489999771118164},{"id":"https://openalex.org/keywords/p53-expression","display_name":"p53 expression","score":0.9079999923706055},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.6859999895095825},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5929999947547913},{"id":"https://openalex.org/keywords/calmodulin","display_name":"calmodulin","score":0.6129999756813049},{"id":"https://openalex.org/keywords/ascites-hepatoma","display_name":"ascites hepatoma","score":0.5929999947547913},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7797684669494629},{"id":"https://openalex.org/C2775891158","wikidata":"https://www.wikidata.org/wiki/Q1752915","display_name":"Trifluoperazine","level":4,"score":0.6067342162132263},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.5901023149490356},{"id":"https://openalex.org/C29688787","wikidata":"https://www.wikidata.org/wiki/Q409145","display_name":"Calmodulin","level":3,"score":0.5836448669433594},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5689482092857361},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5497874617576599},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5385379195213318},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.46507808566093445},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4208948016166687},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3951268792152405},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3790075182914734},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35879528522491455},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.25816014409065247},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19980016350746155},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000470","descriptor_name":"Alkaloids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002147","descriptor_name":"Calmodulin","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D002147","descriptor_name":"Calmodulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002855","descriptor_name":"Chromatography, Thin Layer","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006528","descriptor_name":"Carcinoma, Hepatocellular","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008114","descriptor_name":"Liver Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008114","descriptor_name":"Liver Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008114","descriptor_name":"Liver Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009368","descriptor_name":"Neoplasm Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044182","descriptor_name":"Benzylisoquinolines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12133551","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12133551","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chinese medical journal","raw_type":"Journal Article"},{"id":"mag:2374587160","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12133551","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2069540614","https://openalex.org/W2386654091","https://openalex.org/W2382816261","https://openalex.org/W2160088467","https://openalex.org/W2017182462","https://openalex.org/W2079122811","https://openalex.org/W2379532411","https://openalex.org/W4384932333","https://openalex.org/W2051247611","https://openalex.org/W3042806967"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,15,26,31,57,103,152,203,223,228,262,269,282,292,297,309,316,322,326,336,353,363,369,374],"anti-hepatoma":[4,270,349],"effect":[5,27,61,104,131,350,354],"of":[6,14,28,52,62,105,121,149,165,177,195,205,216,251,272,299,308,355,371],"Calmodulin":[7],"antagonist":[8],"0":[9],"-":[10],"4-ethoxyl-butyl-Berbamine":[11],"(EBB),":[12],"one":[13],"berbamine":[16],"derivatives.":[17],"METHODS:":[18],"Monotetrazolium":[19],"(MTT)":[20],"method":[21],"was":[22,48],"used":[23,100,241],"to":[24,101,168,186,210,360],"analyze":[25],"EBB":[29,63,106,125,150,196,200,232,266,275,283,295,305,381],"on":[30,64,107,132],"proliferation":[32,319],"and":[33,95,113,118,138,159,314,332,351,367,385,391],"growth":[34],"inhibition":[35],"effect.":[36],"Of":[37],"a":[38,127,302,329,347,383],"hepatoma":[39,46,53,122,134,140,312,317,358,390],"cell":[40,108,135,141,154,318,359],"line":[41,136,142],"in":[42,56,72,78,144,222,261,281,291,311,335,373],"vitro.":[43,145],"A":[44],"mouse":[45,139],"model":[47],"induced":[49],"by":[50,227],"injection":[51],"cells":[54,167,313,334],"(H22)":[55],"abdominal":[58],"cavity.":[59],"The":[60,146,163,174,342],"survival":[65],"at":[66,321],"different":[67],"concentrations":[68],"as":[69,71],"well":[70],"combination":[73],"with":[74,192,207,242,253],"5-FU":[75,169,243,263],"were":[76,99,339],"investigated":[77],"vivo.":[79],"Flow":[80],"cytometry":[81],"analysis,":[82],"dot":[83],"blot":[84],"hybridization,":[85],"western":[86],"blot,":[87],"immunochemistry,":[88],"enzyme-linked":[89],"lectin":[90],"assay":[91],"(ELISA),":[92],"trifluoperazine":[93],"(TFP)":[94],"electron":[96],"microscopic":[97],"observation":[98],"study":[102],"cycle":[109,320],"process,":[110],"P53":[111,279,364],"mRNA":[112],"protein":[114,365],"levels,":[115],"calmodulin":[116,303],"content":[117],"ultrastractural":[119],"changes":[120],"cells.":[123],"RESULTS:":[124],"exerts":[126],"very":[128],"strong":[129,348],"inhibitory":[130],"human":[133],"7402":[137],"H22":[143,166,209,255],"IC(50)":[147,175],"value":[148],"for":[151],"two":[153],"lines":[155],"are":[156],"3.312":[157],"microg/ml":[158,184],"1.167":[160],"microg/ml,":[161,188],"respectively.":[162],"sensitivity":[164],"can":[170,179,201,267],"be":[171,180,393],"markedly":[172],"enhanced:":[173],"dosage":[176],"5-Fu":[178,273],"decreased":[181],"from":[182],"0.75":[183],"down":[185],"0.15":[187],"when":[189],"jointly":[190,240],"administered":[191],"nontoxic":[193],"dosages":[194],"(IC(10)).":[197],"In":[198],"vivo,":[199],"prolong":[202],"lifespan":[204],"mice":[206,217,252],"ascites":[208,254],"more":[211],"than":[212,259,289],"three":[213],"months.":[214],"64%":[215],"survived,":[218,256],"while":[219],"all":[220],"animals":[221],"control":[224,293],"group":[225,285],"died":[226],"18th":[229],"day.":[230],"When":[231],"(5":[233],"mg":[234,245],"x":[235,237,246,248],"kg(-1)":[236],"d(-1))":[238],"is":[239,286,382],"(25":[244],"ml(-1)":[247],"d(-1)),":[249],"73%":[250],"much":[257],"higher":[258,288],"27%":[260],"treated":[264,284,337],"group.":[265,294],"enhance":[268],"ability":[271],"treatment.":[274],"mechanism":[276],"against":[277,389],"hepatoma:":[278],"expression":[280,366],"substantially":[287],"that":[290,380],"increased":[296],"translation":[298],"P53.":[300],"As":[301],"antagonist,":[304,344],"decreases":[306,368],"amount":[307,370],"CaM":[310,343,372],"blocked":[315],"G(2)M":[323],"phase.":[324],"Before":[325],"G(0)/G(1)":[327],"phase,":[328],"diploid":[330],"peak":[331],"apoptic":[333],"groups":[338],"observed.":[340],"CONCLUSIONS:":[341],"EBB,":[345],"has":[346],"enhances":[352],"5-FU,":[356],"induces":[357],"apoptosis,":[361],"promotes":[362],"cytoplasm.":[375],"All":[376],"these":[377],"results":[378],"demonstrate":[379],"new":[384],"potentially":[386],"useful":[387],"drug":[388],"should":[392],"researched":[394],"further.":[395]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}